XVIVO Perfusion AB
23.9.2021 09:31:49 CEST | ACCESS Newswire | Press release
GOTHENBURG, SE / ACCESSWIRE / September 23, 2021 / XVIVO Perfusion AB (STO:XVIVO) (LSE:0RKL) (FRA:3XV)
At the XVIVO Capital Markets Day in Gothenburg, Sweden today, CEO Dag Andersson and other senior executives will focus on the company's strategy to become the world leader in the transplant industry.
XVIVO will present five strategic focus areas for the period 2022 - 2026; Global leader Abdominal (with initial focus on the US); Market leading heart preservation system; Increase penetration of machine perfusion; Secure all-inclusive reimbursement in key geographic areas; and China to become the company's second largest market.
"Strategy is about making choices and about deliberately choosing to be different, and always for us considering our overall vision that nobody should die waiting for a new organ. With our five strategic focus areas we have defined our way forward and the keys to our future success " says Dag Andersson, CEO.
During the Capital Markets Day, financial targets and the actions to reach these targets will be presented. XVIVOs ambition is to reach an EBIT-margin of 20 % and an EBITDA-margin of 30 % during the strategy period. In 2026, Abdominal revenue is expected to be of equal size as Thoracic revenue.
XVIVO will continue to build on its world leading position in lung transplantation and develop the offering to cover all four major organs: lung, heart, kidney and liver.
The Capital Markets Day will be broadcasted live online today, on 23 September 2021, at 13:00 CEST via this link: https://xvivo.creo.se/210923 . A recording of the Capital Markets Day will be available on-demand shortly after the event via the same link.
For further information, please contact:
Kristoffer Nordström, CFO and IR, +46 73 519 21 64, e-mail: kristoffer.nordstrom@xvivogroup.com
Anne Lycke, Executive Assistant, +46 735 192 146, e-mail: anne.lycke@xvivogroup.com
About Us
Founded in 1998, XVIVO is the only medical technology company dedicated to extending the life of all major organs - so transplant teams around the world can save more lives. Our solutions allow leading clinicians and researchers to push the boundaries of transplantation medicine. XVIVO is headquartered in Gothenburg, Sweden, and has offices and research sites on two continents. The company is listed on Nasdaq and has the ticker symbol XVIVO. More information can be found on the website www.xvivogroup.com.
This information is information that XVIVO Perfusion AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2021-09-23 09:13 CEST.
Attachments
Language correction: XVIVO Capital Markets Day presents strategic focus areas for 2022-2026
SOURCE: XVIVO Perfusion AB
View source version on accesswire.com:
https://www.accesswire.com/665272/XVIVO-Capital-Markets-Day-Presents-Strategic-Focus-Areas-for-2022-2026
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
FINOS Announces Intent to Form OSERA, a Global Financial Services-Led Alliance for Open Source Supply-Chain Resiliency in the Era of AI26.6.2026 15:00:00 CEST | Press release
Spearheaded by Moderne and Piloted by FINOS Institutional Members, the Open Source Enterprise Resiliency Alliance Mutualizes Open Source 'Backpatching', Promotes Vendor-Neutral Industry-Wide Remediation Standards and Accelerates Evidence-Based, Compliant Open Source Consumption at Scale NEW YORK CITY, NY / ACCESS Newswire / June 26, 2026 / At the Open Source in Finance Forum, FINOS, the financial services arm of the Linux Foundation, announced its intent to form an Open Source Enterprise Resiliency Alliance (OSERA), a global, vendor-neutral, member-governed coalition to strengthen the industry's supply chain resiliency. OSERA will strengthen the open source components that underpin the sector by securing them through a vendor-neutral, upstream-aware approach and accelerating their compliant consumption at scale. The announcement follows a successful Member-only end-to-end pilot phase by Deutsche Bank, Goldman Sachs, Morgan Stanley, Royal Bank of Canada (RBC), and TD Bank Group, in whic
Hydrosat and Kazakhstan Gharysh Sapary Sign Agreement to Advance Satellite-Based Water Intelligence Across Kazakhstan and Central Asia25.6.2026 17:00:00 CEST | Press release
BRUSSELS, BE / ACCESS Newswire / June 25, 2026 / Hydrosat, the leading provider of thermal infrared satellite data and AI-powered analytics, and JSC "NC "Kazakhstan Gharysh Sapary" (JSC "NC "KGS"), Kazakhstan's national space company, announced the signing of a Joint Activity Agreement during a ceremony held in Brussels on 23 June 2026. The agreement establishes the framework for a national-scale program to digitize water resources management using satellite-based thermal analytics and AI, with the potential to expand across Central Asia. The agreement was signed as part of the state visit of the Head of State of the Republic of Kazakhstan to Belgium. During the visit, a number of strategic agreements were concluded to advance artificial intelligence, science, digital infrastructure, and space technologies, creating new opportunities for investment, joint research, technology deployment, and international cooperation. Representing Kazakhstan at the signing ceremonies were Deputy Prime
GA-ASI Adapts Ground Control Station to Fly MQ-9B25.6.2026 16:00:00 CEST | Press release
World Leader in UAS Invests in Upgrades That Ease MQ-9B Procurement SAN DIEGO, CA / ACCESS Newswire / June 25, 2026 / General Atomics Aeronautical Systems, Inc. (GA-ASI) is working to adapt its Block 30 Ground Control Stations (GCS) to fly the company's newer model MQ-9B SkyGuardian® and SeaGuardian® Remotely Piloted Aircraft. When these upgrades are complete, they will enable current users of the Block 30 system, originally designed to fly the MQ-9A Reaper®, to keep that equipment and use it to operate the more capable aircraft. Current users include the U.S. Air Force, U.S. Marine Corps, the Italian Air Force, the French Air Force, the United Arab Emirates Armed Forces, the Spanish Air Force, and the Royal Netherlands Air Force. GA-ASI developed the MQ-9B through its own internal research and development. The upgraded new aircraft required a new and more powerful GCS. The ongoing work with the Block 30 GCS now means that prospective users with existing stocks of equipment wouldn't ne
TIS Warns that Companies are Underprepared for Impact of ISO 20022 Financial Transaction Standard25.6.2026 15:30:00 CEST | Press release
Treasury Intelligence Solutions (TIS) reports that payment disruption is now reaching corporates as banks enforce stricter data standards under the new standard for transaction messaging, and critical gaps are appearing. BERLIN, DE / ACCESS Newswire / June 25, 2026 / TIS today announced a call to action for corporate treasury, finance, and IT teams: ISO 20022 is no longer a bank-only issue, and companies that treat it as simply a messaging upgrade may face payment delays, rejected transactions, higher manual intervention, and reconciliation problems. TIS is the creator of an award-winning cloud-based platform for managing global cash flow, liquidity, and payments. Hundreds of worldwide clients rely on the TIS platform for $80 billion in daily cash management and $2.7 trillion in annual transaction volume. The TIS call to action stems from the SWIFT global financial communication network's steps to phase in ISO 20022 as the sole standard for interbank payment instructions. The new stand
Envision Pharma Group Promotes Jennifer Lospinoso to President, Riparian25.6.2026 15:00:00 CEST | Press release
FAIRFIELD, CT / ACCESS Newswire / June 25, 2026 / Envision Pharma Group (Envision) has appointed Jennifer (Jenn) Lospinoso as President of Riparian, its business unit focused on pricing, access, and value optimization for pharmaceutical and biotech companies. "Jenn's promotion reflects her exceptional leadership, deep industry expertise, and unwavering commitment to clients," said Tom Langan, CEO of Envision. "Riparian represents a significant growth opportunity for Envision, and I'm confident that Jenn and her team will drive the innovation and excellence that sets us apart and delivers for our clients." Lospinoso came to Envision as part of the 2022 acquisition of Riparian, where she served as a key leader. Jenn has built a reputation as a trusted advisor to some of the industry's leading pharmaceutical companies, guiding manufacturers through commercial strategy implementation and navigating statutory and regulatory changes across government programs, including the development of pr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom